The first in-human Phase I study of a BET inhibitor for the treatment of NHL
Can we afford to have CLL patients on a therapy for the rest of their lives?
John Gribben et al.
How far are we from a cure for CLL?
Transplant vs bortezomib and LEN/DEX in multiple myeloma
Overview of a Phase I clinical trial using BGB-3111 for the treatment of relapsed CLL